- Home
- / CytomX Therapeutics
- / Operating Metrics
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
CytomX Therapeutics key operating metrics including Phase I Trials Products, environmental, and social and governance score (ESG).
Phase I Trials Products
1
FY, 2016
Pre-Clinical Phase Products
4
FY, 2016
Patents (US)
13
FY, 2016
Operating Metrics
Environmental, Social and Governance (ESG)
Overall
40-49 out of 100
Community
Employees
Environment
Governance
Premium Content only available in Craft’s Intelligence Portal
Learn moreSource:CSRHub